No Data
No Data
Zhejiang Jiuzhou Pharmaceutical (603456.SH): The plan for some directors and senior management to increase their shareholding in the company has been completed.
On July 23, Glonhui reported that as of the disclosure date of the announcement, Mr. Mei Yi will accumulate a shareholding of 643,300 shares, accounting for 0.0715% of the total share capital of the company, with a shareholding amount of 12.05 million yuan; Mr. Sha Yujie will accumulate a shareholding of 189,400 shares, accounting for 0.0211% of the total share capital of the company, with a shareholding amount of 3.02 million yuan. The shareholding plan is completed.
Benign Growth For Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) Underpins Its Share Price
Zhejiang Jiuzhou Pharmaceutical (603456.SH): Okasipin tablets obtained pharmaceutical registration certificate.
Zhejiang Jiuzhou Pharmaceutical (603456.SH) announced that its controlling subsidiary, Zhejiang Jiuzhou Biomedical Pharmaceutical Co., Ltd., has received the Drug Registration Certificate for Oxcarbazepine Tablets issued by the National Medical Products Administration. Oxcarbazepine tablets are used to treat primary generalized tonic-clonic seizures and partial seizures with or without secondary generalized seizures.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Zhejiang Jiuzhou Pharmaceutical (603456.SH) will distribute a cash dividend of 0.5 yuan per share for the year 2023 on July 4.
Zhejiang Jiuzhou Pharmaceutical (603456.SH) announced that the company will distribute the annual dividend for 2023 on July 4, 2024...
Zhejiang Jiuzhou Pharmaceutical (603456.SH): plans to cancel its subsidiaries Ruibo Life Sciences and Ruibo Europe.
On June 18th, Gelonhui reported that Zhejiang Jiuzhou Pharmaceutical (603456.SH) plans to cancel its subsidiaries, Zhejiang Ruibo Life Science and Technology Co., Ltd. (referred to as "Ruibo Life Science") and Raybow Europe Incorporated ApS (referred to as "Ruibo Europe"), and authorize the management to handle the cancellation matters.
No Data